Ranking and Market Share |
#20 - 1.0% of overall market. 2019 sales: $23 million. 2018 sales: Negligible |
Product Portfolio |
Tinctures (oil), topicals, vapes, and pet |
Distribution Channels |
Dispensaries, mass pharmaceutical retail chains, online |
Positioning |
Trusted, publicly-traded multi-state cannabis operator committing extensive resources, branding, and reputation to CBD sector - aiming to reach both traditional canna users and a much broader new mainstream market; Brand is considered health-and-wellness oriented in cannabis market, which has been advantageous to positioning on CBD side |
Competitive Advantages |
Largest and arguably best-known name in U.S. cannabis market after highly-publicized acquisition of Select, well-positioned to be both recognized by consumers and picked up by major retailers |
Core Competencies |
Solid infrastructure and distribution networks in place rooted in cannabis operations; Brand following and trust already established, especially in recreationally legal cannabis states, which have allowed company to scale quickly |
Making the most money on |
Tinctures |
Doing well |
New entrant to CBD space (late 2018) but scaling extremely quickly, was one of first brands on mass retail shelves - leapfrogging a number of more established contenders |
Niches competitors are missing |
Tremendous foundation of cannabis users looking to purchase from trusted and known entities on CBD market, whether within or outside of dispensaries; Consumers on East Coast, where Curaleaf has a strong presence |
Additional growth opportunities |
Because the company is new to the CBD space it is still working hard to grow distribution channels, especially outside of dedicated dispensaries, which continue to be associated with cannabis and carry deep stigma |
Who do they want to be? |
The most successful operator on both the legal cannabis and CBD-only sides of the market, leveraging extensive resources at their disposal to grow Curaleaf brand presence, value, and popularity nationwide |
Priorities |
Perfecting quality, appeal and innovation of CBD product line to compete with more seasoned veterans and make way onto more mass retail shelves |
Chief competitors |
CBDfx, Medterra |